Sara Schad

1.2k total citations · 1 hit paper
7 papers, 486 citations indexed

About

Sara Schad is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Sara Schad has authored 7 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Sara Schad's work include Phagocytosis and Immune Regulation (3 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Sara Schad is often cited by papers focused on Phagocytosis and Immune Regulation (3 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Sara Schad collaborates with scholars based in United States. Sara Schad's co-authors include Suzan Lazo, Roderick T. Bronson, Mercedes Lobera, Holly Ponichtera, Alexandra L. Pourzia, Anthony Letai, Jessica A. Castrillon, Scott Davis, Alaba Sotayo and Jennifer L. Guerriero and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Sara Schad

6 papers receiving 484 citations

Hit Papers

Class IIa HDAC inhibition reduces breast tumours and meta... 2017 2026 2020 2023 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Schad United States 3 310 213 193 47 36 7 486
Alexandra L. Pourzia United States 2 290 0.9× 194 0.9× 191 1.0× 43 0.9× 37 1.0× 3 442
Brian E. Hsu Canada 7 236 0.8× 146 0.7× 162 0.8× 60 1.3× 37 1.0× 9 425
М. Р. Патышева Russia 9 299 1.0× 231 1.1× 189 1.0× 106 2.3× 39 1.1× 31 525
Hester Franks United Kingdom 11 260 0.8× 84 0.4× 219 1.1× 37 0.8× 12 0.3× 19 421
Denis I. Trufa Germany 13 190 0.6× 155 0.7× 174 0.9× 76 1.6× 17 0.5× 21 421
Yigang Qian China 8 249 0.8× 130 0.6× 295 1.5× 86 1.8× 21 0.6× 12 479
Susanna Lauttia Finland 5 210 0.7× 152 0.7× 218 1.1× 69 1.5× 27 0.8× 6 389
Zuzanna Rydzyńska Poland 5 269 0.9× 114 0.5× 123 0.6× 79 1.7× 17 0.5× 8 413
Andrea M. Chambers United States 7 304 1.0× 72 0.3× 252 1.3× 56 1.2× 22 0.6× 7 409
Ryan Lupo United States 6 110 0.4× 248 1.2× 166 0.9× 111 2.4× 15 0.4× 7 399

Countries citing papers authored by Sara Schad

Since Specialization
Citations

This map shows the geographic impact of Sara Schad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Schad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Schad more than expected).

Fields of papers citing papers by Sara Schad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Schad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Schad. The network helps show where Sara Schad may publish in the future.

Co-authorship network of co-authors of Sara Schad

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Schad. A scholar is included among the top collaborators of Sara Schad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Schad. Sara Schad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hackett, Christopher S., Daniel Hirschhorn, Alessandra Piersigilli, et al.. (2024). TYRP1 directed CAR T cells control tumor progression in preclinical melanoma models. SHILAP Revista de lepidopterología. 32(3). 200862–200862. 2 indexed citations
2.
Mangarin, Levi, Stephen Martis, Sara Schad, et al.. (2023). 968 PD-1hiFoxp3-CD4+ tumor-infiltrating T-cell lineage commitment impacts the immunotherapy outcome. SHILAP Revista de lepidopterología. A1075–A1075. 1 indexed citations
3.
Budhu, Sadna, Rachel Giese, Aditi Gupta, et al.. (2021). Targeting Phosphatidylserine Enhances the Anti-tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of Melanoma. Cell Reports. 34(2). 108620–108620. 31 indexed citations
4.
Schad, Sara, Daniel Hirschhorn-Cymerman, Sadna Budhu, et al.. (2020). Phosphatidylserine targeting antibody enhances anti-tumor activity of adoptive cell therapies in a mouse melanoma model. The Journal of Immunology. 204(1_Supplement). 170.5–170.5.
5.
Chow, Andrew, Sara Schad, Sai Kiran Sharma, et al.. (2019). Abstract 978: Tim-4+ tissue-resident macrophages impair antitumor T-cell immunity. Cancer Research. 79(13_Supplement). 978–978. 1 indexed citations
6.
Guerriero, Jennifer L., Alaba Sotayo, Holly Ponichtera, et al.. (2017). Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages. Nature. 543(7645). 428–432. 432 indexed citations breakdown →
7.
Zhang, Jibo, et al.. (2015). Nuclear import of the thyroid hormone receptor α1 is mediated by importin 7, importin β1, and adaptor importin α1. Molecular and Cellular Endocrinology. 419. 185–197. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026